MARKET

ALXN

ALXN

Alexion Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

107.13
-2.31
-2.11%
Closed 18:09 11/13 EST
OPEN
109.02
PREV CLOSE
109.44
HIGH
109.02
LOW
106.73
VOLUME
1.42M
TURNOVER
--
52 WEEK HIGH
141.86
52 WEEK LOW
92.56
MARKET CAP
23.71B
P/E (TTM)
17.75
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ALXN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 21 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ALXN News

  • 5 Most-Loved S&P 500 Stocks on Wall Street
  • Zacks.23h ago
  • Alexion to Present at the 2019 Stifel Healthcare Conference
  • Business Wire.1d ago
  • Sales winners in the third quarter include Netflix, Autodesk and PayPal
  • MarketWatch.1d ago
  • Buy Big Biotech — But Not Gilead, Analyst Says
  • Barrons.com.1d ago

More

Industry

Pharmaceuticals
+0.07%
Pharmaceuticals & Medical Research
+0.16%

Hot Stocks

Name
Price
%Change

About ALXN

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous). Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP). Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). It is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.
More

Webull offers Alexion Pharmaceuticals, Inc. (ALXN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.